DE PETRO, Giuseppina
 Distribuzione geografica
Continente #
NA - Nord America 8.931
EU - Europa 6.464
AS - Asia 5.941
SA - Sud America 1.095
AF - Africa 125
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 23
AN - Antartide 1
Totale 22.603
Nazione #
US - Stati Uniti d'America 8.710
CN - Cina 2.044
SG - Singapore 1.954
PL - Polonia 1.494
DE - Germania 1.159
UA - Ucraina 953
BR - Brasile 905
IT - Italia 862
HK - Hong Kong 511
FR - Francia 434
FI - Finlandia 428
VN - Vietnam 400
GB - Regno Unito 333
IN - India 306
RU - Federazione Russa 275
TR - Turchia 205
IE - Irlanda 158
BD - Bangladesh 152
CA - Canada 125
SE - Svezia 105
AR - Argentina 74
ID - Indonesia 74
MX - Messico 62
BE - Belgio 53
NL - Olanda 47
IQ - Iraq 42
JP - Giappone 42
ZA - Sudafrica 40
EC - Ecuador 35
AT - Austria 34
ES - Italia 34
PK - Pakistan 28
AU - Australia 21
EU - Europa 21
RO - Romania 20
SA - Arabia Saudita 20
CO - Colombia 18
KR - Corea 18
PY - Paraguay 17
JO - Giordania 15
KE - Kenya 15
AE - Emirati Arabi Uniti 14
IR - Iran 14
MA - Marocco 14
CH - Svizzera 13
UZ - Uzbekistan 13
CL - Cile 12
VE - Venezuela 12
CZ - Repubblica Ceca 11
LT - Lituania 11
NG - Nigeria 11
JM - Giamaica 10
OM - Oman 10
AZ - Azerbaigian 9
IL - Israele 8
TH - Thailandia 8
BO - Bolivia 7
EG - Egitto 7
KZ - Kazakistan 7
MU - Mauritius 7
PE - Perù 7
SD - Sudan 7
UY - Uruguay 7
CR - Costa Rica 6
DZ - Algeria 6
MY - Malesia 6
RS - Serbia 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
LY - Libia 5
TW - Taiwan 5
BH - Bahrain 4
PT - Portogallo 4
BG - Bulgaria 3
BY - Bielorussia 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
HN - Honduras 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
NP - Nepal 3
PA - Panama 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
AO - Angola 2
GE - Georgia 2
KG - Kirghizistan 2
LB - Libano 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
RE - Reunion 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
TM - Turkmenistan 2
Totale 22.580
Città #
Warsaw 1.488
Singapore 1.049
Ashburn 722
Jacksonville 674
Fairfield 605
Hong Kong 500
Woodbridge 469
Chandler 465
Beijing 431
Ann Arbor 391
San Jose 365
The Dalles 360
Houston 322
Wilmington 294
Princeton 288
New York 271
Nanjing 266
Cambridge 263
Helsinki 256
Seattle 238
Brescia 237
Los Angeles 215
Lauterbourg 161
Dublin 157
Dearborn 151
Istanbul 149
Ho Chi Minh City 132
Council Bluffs 126
Buffalo 113
Des Moines 110
Munich 107
Chicago 91
Nanchang 91
Milan 89
Dallas 86
São Paulo 80
Moscow 76
Shenyang 72
Orem 71
Dong Ket 70
Jinan 68
Hebei 67
Changsha 63
San Francisco 62
Shanghai 62
Redondo Beach 52
Tianjin 52
Santa Clara 51
Hanoi 50
Brussels 49
Jiaxing 49
Lancaster 48
Jakarta 47
Kunming 41
Toronto 38
Pune 35
Turku 35
Rio de Janeiro 34
Tokyo 34
Brooklyn 32
San Diego 31
Chennai 30
Guangzhou 30
Hangzhou 28
London 28
Atlanta 27
Lappeenranta 27
Montreal 26
Salt Lake City 26
Verona 26
Zhengzhou 26
Johannesburg 25
Kocaeli 25
Mexico City 25
Mumbai 25
Phoenix 25
Amsterdam 24
Frankfurt am Main 24
Nuremberg 23
Rome 23
Denver 19
North York 19
Charlotte 18
Ningbo 18
Nürnberg 17
Boardman 16
Boston 16
Manchester 16
Tampa 16
Vienna 16
Baghdad 15
Belo Horizonte 15
Da Nang 15
Philadelphia 15
Stockholm 15
Amman 14
Bari 14
Brasília 14
Curitiba 14
Hefei 14
Totale 13.910
Nome #
Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis 352
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 338
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 320
Environment and bladder cancer: molecular analysis by interaction networks 318
Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis 290
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 264
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 259
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 255
RET/PTC-1-driven transformation and pro-invasive phenotype of human thyrocytes depend on MET induction and alpha-catenin nuclear translocation 248
Transmembrane protein TMEM230, regulator of metalloproteins and motor proteins in gliomas and gliosis 240
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 230
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 223
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 223
Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers 222
Functional Role of microRNA-23b-3p in Cancer Biology 221
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 219
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 215
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC 210
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 207
De novo 1Mb interstitial deletion of 8p22 in a patient with slight mental retardation and speech delay. 207
Biological Function of MicroRNA193a-3p in Health and Disease 206
miR103 e miR-107 sono coinvolti nella regolazione dell'espressione di CDK5R1/p35 implicato nella migrazione neuronale. 192
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC 188
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC. 187
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 183
Preparazione di colture primarie di fibroblasti di embrione di pollo . 182
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 181
microRNAs and human hepatocellular carcinoma 179
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 177
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 173
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 172
The study of HCC cell specific miRNas reveals one novel human miR and miR-21, miR24 and miR-27a differential expression in HCC 170
Determination of plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 167
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 166
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 164
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC. 163
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 161
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 160
RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinoma 159
The analysis of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24, and miR-27a differential expression in cirrhotic/non- cirrhotic HCC. 152
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 152
Characterization of a 13 aminoacid human fibronectin peptide induce matrix assembly and inhibiting migration and invasion in tumor cells 150
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 149
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 149
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 149
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 146
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 146
Sequential analysis of multistage hepatocarcinogenesis reveals that miR100 and PLK1 dysregulation is an early event maintained along tumor progression. 145
Expression of Cellular and Extracellular TERRA, TERC and TERT in Hepatocellular Carcinoma 139
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 138
A rapid and highly sensitive solid phase enzyme immunoassay specific for human fibronectin using a characterized monoclonal antibody 138
Transformation enhancing activity present in the plasma of cancer patients binds to gelatin. 137
Transformation-enhancing activity of gelatin binding fragments of fibronectin 136
"Trasformazione indotta dai virus oncogeni ad RNA. Tecniche di produzione e titolazione del RSV in colture di fibroblasti di embrione di pollo" pp. 27- 34, settembre 1987, in: , CLEUP-Padova, Italia. 135
Matrix assembly induction and cell migration and invasion inhibition by a 13-amino acid fibronectin peptide 134
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 134
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study 134
Evidence for preferential proteolytic cleavage of one of the two fibronectin subunits and for immunological localization of a site distinguishing them 133
Gene response of human skin fibroblasts to urokinase- and tissue-type plasminogen activators. 133
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK-1 dysregulation is an early event maintained along tumor progression. 133
DNA methylation variations in familial female and male breast cancer 133
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 132
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells 132
miRNA Editing: New Insights into the Fast Control of Gene Expression in Health and Disease 132
Urokinase and c-met are target of miR-23b in human cells. 130
Plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 129
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. 129
Interaction of tissue type plasminogen activator with fibronectin and fibronectin fragments 129
Prevalence and features of delirium in older patients admitted to rehabilitation facilities: a multicenter study 128
Androgen receptor mRNA under-expression in poorly differentiated human hepatocellular carcinoma. 127
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 126
Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. 125
Transformation enhancing activity in plasma of tumor patients: relationship with fibronectin fragments 125
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 125
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 124
Emerging role of Telomeric-Repeat containing RNA TERRA in hepatocellular carcinoma 124
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 123
Inhibition of Rous sarcoma virus-induced transformation by proteins involved in blood coagulation 122
Studi per lo sviluppo di terapie innovative molecolari per l’epatocarcinoma cellulare: microRNA e sorafenib. 122
Endocannabinoid system in inflammatory bowel diseases: mucosal gene expression preliminary data 121
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 120
Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer 120
Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts 118
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 118
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 118
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 117
Circulating microRNA-23b-3p and tissue microRNA-193a-3p as promising molecular biomarkers in human hepatocellular carcinoma. 116
La trascrizione in Molecole, cellule e Organismi 116
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 115
Role of fibronectin degradation products on cellular transformation. 115
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 115
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 114
Conditional interactions of fibronectin: C-reactive protein, sulfated proteoglycans, and malignant transformation. 114
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 113
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 112
Tecniche di conservazione delle cellule mediante congelamento. 112
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 111
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 111
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 111
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 110
Totale 16.187
Categoria #
all - tutte 97.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.280


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.186 62 215 56 73 10 41 49 68 67 127 130 288
2022/20231.248 186 64 35 123 119 296 13 104 187 10 48 63
2023/20241.308 95 31 137 75 63 274 83 46 233 53 28 190
2024/20253.527 41 64 66 462 326 306 283 119 442 186 802 430
2025/20266.452 600 850 477 935 626 518 880 255 394 557 248 112
2026/202779 79 0 0 0 0 0 0 0 0 0 0 0
Totale 22.959